NF-κB interacting lncRNA (NKILA) directly blocks IκB phosphorylation to form a stable ternary complex NF-κB/IκB/NKILA that represses cancer-associated inflammation in breast cancer [149]. Here, NFKB1 is linked to breast carcinoma.